The Use of a Synthetic Cannabinoid in the Management of Treatment-Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)UpdatedSeptember 17, 2021 Print You are here: KB Home Articles by Topic Medical Cannabis The Use of a Synthetic Cannabinoid in the Management of Treatment-Resistant Nightmares in Posttraumatic Stress Disorder (PTSD) < BackSorry, but you do not have permission to view this content.